Synthomer (LSE:SYNT) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)

View and export this data going back to 1971. Start your Free Trial

What is Synthomer Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Synthomer's Capital Expenditure for the six months ended in Dec. 2023 was £-50.10 Mil. Its Operating Income for the six months ended in Dec. 2023 was £-4.20 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Synthomer Capex-to-Operating-Income Historical Data

The historical data trend for Synthomer's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthomer Capex-to-Operating-Income Chart

Synthomer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Operating-Income

Get a 7-Day Free Trial

0.60

0.34

0.21

0.74

Synthomer Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Operating-Income	Get a 7-Day Free Trial															0.40	0.29	6.26	-	-

Competitive Comparison of Synthomer's Capex-to-Operating-Income

For the Specialty Chemicals subindustry, Synthomer's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synthomer's Capex-to-Operating-Income Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Synthomer's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Synthomer's Capex-to-Operating-Income falls into.

Synthomer Capex-to-Operating-Income Calculation

Synthomer's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-84)	/	-13
	=	N/A

Synthomer's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-50.1)	/	-4.2
	=	N/A

Synthomer (LSE:SYNT) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Synthomer Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Synthomer's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Synthomer (LSE:SYNT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Synthomer PLC (LSE:SYNT) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

SYYYF:USA SYNTl:UK 7YC2:Germany

Address

45 Pall Mall, London, GBR, SW1Y 5JG

Website

https://www.synthomer.com

Synthomer PLC is a specialty chemicals company. It supplies a variety of chemicals including latex and adhesives, which are used in a wide range of markets such as construction, coatings, textiles, paper, and healthcare. The company's products include styrene-butadiene rubber, which is used to make coated paper, packaging, bindings for carpet, foam mattresses, pillows and shoes; and nitrile butadiene latex used to make medical gloves and catheters, among others. The company organizes itself into five segments: performance elastomers, functional solutions, industrial specialties, adhesive Technologies and acrylate monomers. A vast majority of the company's revenue is generated by the performance elastomers and functional solutions segments combined.